UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 520

Sortiert nach

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

Annals of oncology, 2011-03, Vol.22 (3), p.515-523

2011

Volltextzugriff (PDF)

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer

British journal of cancer, 2013-03, Vol.108 (5), p.1052-1060

2013

Volltextzugriff (PDF)

Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression

Breast cancer research : BCR, 2019-02, Vol.21 (1), p.28-28, Article 28

2019

Volltextzugriff (PDF)

Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study

British journal of dermatology (1951), 2020-06, Vol.182 (6), p.1369-1378

2020

Volltextzugriff (PDF)

Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting

British journal of cancer, 2013-04, Vol.108 (6), p.1358-1367

2013

Volltextzugriff (PDF)

Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial

European journal of cancer (1990), 2018-08, Vol.99, p.1-8

2018

Volltextzugriff (PDF)

Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study

Journal of the European Academy of Dermatology and Venereology, 2018-03, Vol.32 (3), p.372-381

2018

Volltextzugriff (PDF)

A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2– advanced breast cancer (BELLE-4)

Annals of oncology, 2017-02, Vol.28 (2), p.313-320

2017

Volltextzugriff (PDF)

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

Annals of oncology, 2008-03, Vol.19 (3), p.420-432

2008

Volltextzugriff (PDF)

Blood microvessel density, lymphatic microvessel density and lymphatic invasion in predicting melanoma metastases: systematic review and meta-analysis

British journal of dermatology (1951), 2014-01, Vol.170 (1), p.66-77

2014

Volltextzugriff (PDF)

First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours

British journal of cancer, 2006-12, Vol.95 (12), p.1611-1625

2006

Volltextzugriff (PDF)

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19 mammaglobin RT-PCR in patients with metastatic breast cancer

British journal of cancer, 2010-01, Vol.102 (2), p.276-284

2010

Volltextzugriff (PDF)

Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype

British journal of cancer, 2010-08, Vol.103 (4), p.532-541

2010

Volltextzugriff (PDF)

A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer

Breast (Edinburgh), 2020-10, Vol.53, p.212-220

2020

Volltextzugriff (PDF)

Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer

Annals of oncology, 2009-04, Vol.20 (4), p.615-620

2009

Volltextzugriff (PDF)

Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours

European Journal of Cancer, 2002-08, Vol.38 (12), p.1564-1579

2002

Volltextzugriff (PDF)

Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes

British journal of cancer, 2014-01, Vol.110 (2), p.375-383

2014

Volltextzugriff (PDF)

Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapy

Annals of oncology, 2013-01, Vol.24 (1), p.109-116

2013

Volltextzugriff (PDF)

Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer

British journal of cancer, 2006-03, Vol.94 (5), p.672-680

2006

Volltextzugriff (PDF)

Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients

Annals of oncology, 2015-03, Vol.26 (3), p.510-516

2015

Volltextzugriff (PDF)

Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia

British journal of cancer, 2004-04, Vol.90 (7), p.1429-1436

2004

Volltextzugriff (PDF)

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

Annals of oncology, 2001-02, Vol.12 (2), p.259-266

2001

Volltextzugriff (PDF)

Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer

British journal of cancer, 2002-02, Vol.86 (3), p.389-395

2002

Volltextzugriff (PDF)

Mechanisms of tumour vascularization in cutaneous malignant melanoma: clinical implications

British journal of dermatology (1951), 2014-08, Vol.171 (2), p.220-233

2014

Volltextzugriff (PDF)

Elevated driver mutational burden or number of perturbed pathways and poor response to abiraterone or enzalutamide in metastatic castration-resistant prostate cancer

ANNALS OF ONCOLOGY, 2019, Vol.30, p.v30-v31

2019

Volltextzugriff (PDF)

1 – 25 von 520

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(492)
Mit Volltextzugriff
(504)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer

Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression

Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study

Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting

Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial

Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study

A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2– advanced breast cancer (BELLE-4)

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

Blood microvessel density, lymphatic microvessel density and lymphatic invasion in predicting melanoma metastases: systematic review and meta-analysis

First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19 mammaglobin RT-PCR in patients with metastatic breast cancer

Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype

A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer

Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer

Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours

Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes

Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapy

Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer

Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients

Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer

Mechanisms of tumour vascularization in cutaneous malignant melanoma: clinical implications

Elevated driver mutational burden or number of perturbed pathways and poor response to abiraterone or enzalutamide in metastatic castration-resistant prostate cancer

Suchergebnisse filtern